Research and experimental development on biotechnology
Registered Address
10 john street, london, WC1N 2EB
Website
-
bio-life technology limitedEstimated Valuation
£17.6k
Pomanda estimates the enterprise value of BIO-LIFE TECHNOLOGY LIMITED at £17.6k based on a Turnover of £17.3k and 1.02x industry multiple (adjusted for size and gross margin).
bio-life technology limitedEstimated Valuation
£0
Pomanda estimates the enterprise value of BIO-LIFE TECHNOLOGY LIMITED at £0 based on an EBITDA of £0 and a 4.01x industry multiple (adjusted for size and gross margin).
bio-life technology limitedEstimated Valuation
£0
Pomanda estimates the enterprise value of BIO-LIFE TECHNOLOGY LIMITED at £0 based on Net Assets of £-836 and 1.79x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Bio-life Technology LimitedOverview
Bio-life Technology Limited is a dissolved company that was located in london, WC1N 2EB with a Companies House number of 05019962. It operated in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in January 2004, it's largest shareholder was
oury biotech ventures
with a 100% stake. The last turnover for Bio-life Technology Limited was estimated at £17.3k.
Pomanda's financial health check has awarded Bio-Life Technology Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 7 areas for improvement. Company Health Check FAQs
Health Rating2out of 5
2 Strong
1 Regular
7 Weak
Size
annual sales of £17.3k, make it smaller than the average company (£2.8m)
£17.3k - Bio-life Technology Limited
£2.8m - Industry AVG
Growth
3 year (CAGR) sales growth of 4%, show it is growing at a slower rate (12.1%)
4% - Bio-life Technology Limited
12.1% - Industry AVG
Production
with a gross margin of 29.5%, this company has a higher cost of product (49.9%)
29.5% - Bio-life Technology Limited
49.9% - Industry AVG
Profitability
an operating margin of 0% make it more profitable than the average company (-12%)
0% - Bio-life Technology Limited
-12% - Industry AVG
Employees
with 1 employees, this is below the industry average (39)
1 - Bio-life Technology Limited
39 - Industry AVG
Pay Structure
on an average salary of £68.5k, the company has an equivalent pay structure (£68.5k)
£68.5k - Bio-life Technology Limited
£68.5k - Industry AVG
Efficiency
resulting in sales per employee of £17.3k, this is less efficient (£113.9k)
£17.3k - Bio-life Technology Limited
£113.9k - Industry AVG
Debtor Days
it gets paid by customers after 113 days, this is later than average (51 days)
113 days - Bio-life Technology Limited
51 days - Industry AVG
Creditor Days
its suppliers are paid after 185 days, this is slower than average (46 days)
185 days - Bio-life Technology Limited
46 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Bio-life Technology Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Bio-life Technology Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 115.6%, this is a higher level of debt than the average (44.4%)
115.6% - Bio-life Technology Limited
44.4% - Industry AVG
BIO-LIFE TECHNOLOGY LIMITED financials
EXPORT
Bio-Life Technology Limited's latest turnover from December 2019 is estimated at £17.3 thousand and the company has net assets of -£836. According to their latest financial statements, we estimate that Bio-Life Technology Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Turnover
17,331
17,738
15,521
15,301
15,675
14,880
14,941
Other Income Or Grants
Cost Of Sales
12,218
12,626
10,987
10,965
11,030
10,471
10,750
Gross Profit
5,113
5,113
4,534
4,337
4,644
4,409
4,191
Admin Expenses
5,113
5,113
4,533
4,337
4,644
4,409
5,028
-1,132
1,000
Operating Profit
1
-837
1,132
-1,000
Interest Payable
Interest Receivable
Pre-Tax Profit
1
-837
1,132
-1,000
Tax
-294
Profit After Tax
1
-837
838
-1,000
Dividends Paid
Retained Profit
1
-837
838
-1,000
Employee Costs
68,485
67,868
60,980
57,793
54,775
56,317
53,258
Number Of Employees
1
1
1
1
1
1
1
1
EBITDA*
1
-837
1,132
-1,000
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Tangible Assets
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
Stock & work in progress
Trade Debtors
5,376
5,376
5,376
5,376
5,376
5,376
5,376
5,375
5,375
Group Debtors
Misc Debtors
1
1
Cash
misc current assets
total current assets
5,376
5,376
5,376
5,376
5,376
5,376
5,376
5,376
5,376
total assets
5,376
5,376
5,376
5,376
5,376
5,376
5,376
5,376
5,376
Bank overdraft
Bank loan
Trade Creditors
6,212
6,212
6,212
6,212
6,212
6,212
6,212
1,175
1,175
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities
5,038
5,038
total current liabilities
6,212
6,212
6,212
6,212
6,212
6,212
6,212
6,213
6,213
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities
6,212
6,212
6,212
6,212
6,212
6,212
6,212
6,213
6,213
net assets
-836
-836
-836
-836
-836
-836
-836
-837
-837
total shareholders funds
-836
-836
-836
-836
-836
-836
-836
-837
-837
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Operating Activities
Operating Profit
1
-837
1,132
-1,000
Depreciation
Amortisation
Tax
-294
Stock
Debtors
5,376
-5,376
5,376
Creditors
6,212
-1,175
1,175
Accruals and Deferred Income
-5,038
5,038
Deferred Taxes & Provisions
Cash flow from operations
1
-1
1
-163
Investing Activities
capital expenditure
Change in Investments
cash flow from investments
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
-1
1
-1
163
interest
cash flow from financing
-1
1
-1
163
cash and cash equivalents
cash
overdraft
change in cash
bio-life technology limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for bio-life technology limited. Get real-time insights into bio-life technology limited's credit score, group structure and payment trends.
Perform a competitor analysis for bio-life technology limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other undefined companies, companies in WC1N area or any other competitors across 12 key performance metrics.
bio-life technology limited Ownership
BIO-LIFE TECHNOLOGY LIMITED group structure
Bio-Life Technology Limited has no subsidiary companies.
Ultimate parent company
BIO-LIFE TECHNOLOGY LIMITED
05019962
BIO-LIFE TECHNOLOGY LIMITED Shareholders
The sole shareholder of Bio-Life Technology Limited is Oury Biotech Ventures.
oury biotech ventures
100%
bio-life technology limited directors
Bio-Life Technology Limited currently has 1 director, Mr James Oury serving since Jan 2004.
72110 - Research and experimental development on biotechnology
incorporation date
January 2004
age
21
incorporated
UK
ultimate parent company
None
accounts
Micro-Entity Accounts
last accounts submitted
December 2019
previous names
N/A
accountant
-
auditor
-
address
10 john street, london, WC1N 2EB
Bank
-
Legal Advisor
-
bio-life technology limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to bio-life technology limited.
bio-life technology limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for BIO-LIFE TECHNOLOGY LIMITED. This can take several minutes, an email will notify you when this has completed.
bio-life technology limitedCompanies House Filings - See Documents
